Latest Form 4 insider transactions

Clark David Bersaglini, Vice President of Kennametal Inc, reported multiple transactions in common stock on August 14, 2026.

Stavros G. Vizirgianakis, a Director of Xtant Medical Holdings, Inc., received 323,275 shares of common stock on August 15, 2026.

Bradley Ramberg, SEE REMARKS of Beachbody Company, Inc., received 3,556 shares of common stock on August 15, 2026.

Kashif Rashid, Chief Legal Officer of Sight Sciences, Inc., received 181,818 shares of common stock on August 10, 2026.

Marcus C Rowland, a Director of Crescent Energy Co, reported a transaction in 3,500 shares of common stock on August 14, 2026.

Mark R Goldston, Executive Chairman and a Director of Beachbody Company, Inc., received 100,000 shares of common stock on August 15, 2026.

Judith L Bacchus, Vice President of Kennametal Inc, reported multiple transactions in common stock on August 14, 2026.

Thomas Trimarchi, President and CFO of BridgeBio Pharma, Inc., reported a transaction in 22,781 shares of common stock on August 16, 2026.

Mark A. Schallenberger, Chief Operating Officer of Xtant Medical Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.

Neil Kumar, Chief Executive Officer and a Director of BridgeBio Pharma, Inc., reported multiple transactions in common stock on August 16, 2026.

Maricel Apuli, Chief Accounting Officer of BridgeBio Pharma, Inc., reported a transaction in 4,714 shares of common stock on August 16, 2026.

James Nelson Pepin, Gen Counsel and Corp Secretary of Immatics N.V., reported multiple transactions in common stock on August 14, 2026.

Andrew Enrietti, See Remarks of Viatris Inc, reported multiple transactions in common stock on August 15, 2026.

Darren Graeler, Chief Accounting Officer of loanDepot, Inc., reported multiple transactions in common stock on August 17, 2026.

Christopher M. Capozzi, Chief Financial Officer of Ethos Technologies Inc., sold 26,184 shares of common stock on August 17, 2026.

Peter George Colis, CEO and Secretary and a Director of Ethos Technologies Inc., sold 29,342 shares of common stock on August 17, 2026.

Lingke Wang, President and a Director of Ethos Technologies Inc., sold 22,623 shares of common stock on August 17, 2026.

Brandt Walter Kucharski, Chief Accounting Officer of Ethos Technologies Inc., sold 83,047 shares of common stock on August 14, 2026.

William George Iii, CHIEF FINANCIAL OFFICER of Comfort Systems Usa Inc, sold 2,554 shares of common stock on August 17, 2026 for $1,859.65 per share.

Shanti B. Gupta, Chief Operating Officer of AST SpaceMobile, Inc., reported a transaction in 12,767 shares of common stock on August 15, 2026.

Andrew Martin Johnson, CFO and CLO and a Director of AST SpaceMobile, Inc., reported multiple transactions in common stock on August 15, 2026.

Maya Bernal, Chief Accounting Officer of AST SpaceMobile, Inc., reported a transaction in 2,919 shares of common stock on August 15, 2026.

Scott Wisniewski, President of AST SpaceMobile, Inc., reported multiple transactions in common stock on August 15, 2026.

Ronald J Glahn, SVP, Global Sales, Broadband of Harmonic Inc, reported multiple transactions in common stock on August 15, 2026.

Jonathan S Beatty, MD, Head of Advisor Services of Schwab Charles Corp, sold 1,000 shares of common stock on August 17, 2026 for $111.33 per share.

Scott C Neils, CFO and Assistant Secretary of Xtant Medical Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.

Kevin Hillesland, SVP, Structured Finance of Gatx Corp, reported a transaction in 70 shares of common stock on August 15, 2026.

Jason Lettmann, CHIEF EXECUTIVE OFFICER and a Director of Alx Oncology Holdings Inc, sold 2,230 shares of common stock on August 17, 2026 for $1.93 per share.

Mauad Bruno Sousa, a Director of Aura Minerals Inc., purchased 11,000 shares of common stock on August 17, 2026 for $78.93 per share.

Shelly Wong, SVP, FINANCE AND CAO of Alx Oncology Holdings Inc, sold 573 shares of common stock on August 17, 2026 for $1.93 per share.